IL6 and amyotrophic lateral sclerosis: Evidence from experimental studies, such as that by Johnson et al. [45], demonstrated that butyrate has anti-inflammatory effects, reducing levels of pro-inflammatory cytokines like TNF-α and IL-6, which are implicated in ALS pathogenesis.